Systematic Review and Meta-Analysis Examining the Effect of Upregulation and Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 in Mouse Models of Abdominal Aortic Aneurysm
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.126.324982 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Callan D Wesley und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry (C.D.W., S.T., J.G.), James Cook University, Townsv…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Proprotein Convertase 9, PCSK9 Inhibitors, Aorta, Abdominal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Abdominal aortic aneurysm (AAA) rupture is an important cause of death worldwide, with no effective drug therapies currently available. PCSK9 (proprotein convertase subtilisin/kexin type 9) regulates LDL-C (low-density lipoprotein-cholesterol) and modulates vascular inflammation, smooth muscle cell apoptosis, and extracellular matrix remodeling, all implicated in AAA pathogenesis. METHODS: We conducted a systematic review and meta-analysis of studies evaluating the effects of PCSK9 upregulation or inhibition on AAA in mouse models. The primary outcome was AAA diameter, with secondary outcomes including lipid and inflammatory markers. Five articles (11 studies, 101 experimental, and 84 control mice) were included. Meta-analysis results were reported as standardized mean difference and 95% CIs. A custom tool, which integrated Cochrane criteria, ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines, and methods from prior systematic reviews, was used to assess the risk of bias. RESULTS: PCSK9 upregulation significantly increased AAA diameter (standardized mean difference, 1.07 [95% CI, 0.33–1.81]; P =0.005) and blood concentrations of total cholesterol, LDL (low-density lipoprotein), and triglycerides while significantly reducing blood concentrations of high-density lipoprotein. PCSK9 upregulation also increased aortic IL (interleukin)-6 and IL1-β concentrations, as assessed by aortic immunohistochemical staining. PCSK9 inhibition significantly reduced AAA diameter (standardized mean difference, −0.97 [95% CI, −1.44 to −0.49]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry (C.D.W., S.T., J.G.), James Cook University, Townsville, Queensland.
- The Australian Institute of Tropical Health and Medicine (C.D.W., S.T., J.G.), James Cook University, Townsville, Queensland.
- Department of Vascular Surgery, Cairns Hospital, Queensland, Australia (A.K.).
- Department of Vascular and Endovascular Surgery, Townsville University Hospital, Queensland, Australia (J.G.).
ORCID-Profile: Callan D Wesley, Shivshankar Thanigaimani, Abid Khan, Jonathan Golledge
Zitieren
APA
Wesley, C. D., Thanigaimani, S., Khan, A., & Golledge, J. (2026). Systematic Review and Meta-Analysis Examining the Effect of Upregulation and Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 in Mouse Models of Abdominal Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.324982
Vancouver
Wesley CD, Thanigaimani S, Khan A, Golledge J. Systematic Review and Meta-Analysis Examining the Effect of Upregulation and Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 in Mouse Models of Abdominal Aortic Aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.324982
BibTeX
@article{Wesley2026,
author = {Wesley, Callan D and Thanigaimani, Shivshankar and Khan, Abid and Golledge, Jonathan},
title = {Systematic Review and Meta-Analysis Examining the Effect of Upregulation and Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 in Mouse Models of Abdominal Aortic Aneurysm},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.126.324982}
}
EUVIMED